Fecal calprotectin testing reimbursement guidance
Defines UnitedHealthcare Medicare Advantage reimbursement guidance for fecal calprotectin testing (procedure code 83993) and lists conditions under which it will be considered for reimbursement; applies to providers billing Medicare Advantage plans.
No material clinical or coverage changes in this revision.
Coverage Criteria — When Testing Will Be Reimbursed
Fecal calprotectin reimbursement criteria
Reimbursement will be considered for fecal calprotectin testing when billed for specified conditions using procedure code 83993.
AND billed for one of the following conditions
- A condition listed in this policy (see policy conditions list) is the indication for testing.
Procedure Codes and Coding Guidance
| 83993 | Calprotectin, fecal |
Provider Billing and Reimbursement Actions
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.